vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $51.2M, roughly 1.5× Plymouth Industrial REIT, Inc.). On growth, Plymouth Industrial REIT, Inc. posted the faster year-over-year revenue change (-1.4% vs -36.9%). Over the past eight quarters, Plymouth Industrial REIT, Inc.'s revenue compounded faster (0.4% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.

MED vs PLYM — Head-to-Head

Bigger by revenue
MED
MED
1.5× larger
MED
$75.1M
$51.2M
PLYM
Growing faster (revenue YoY)
PLYM
PLYM
+35.5% gap
PLYM
-1.4%
-36.9%
MED
Faster 2-yr revenue CAGR
PLYM
PLYM
Annualised
PLYM
0.4%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MED
MED
PLYM
PLYM
Revenue
$75.1M
$51.2M
Net Profit
$-54.4M
Gross Margin
69.4%
Operating Margin
-10.4%
-102.5%
Net Margin
-106.3%
Revenue YoY
-36.9%
-1.4%
Net Profit YoY
-248.5%
EPS (diluted)
$-1.64
$-1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
PLYM
PLYM
Q4 25
$75.1M
Q3 25
$89.4M
$51.2M
Q2 25
$105.6M
$47.2M
Q1 25
$115.7M
$45.6M
Q4 24
$119.0M
$47.6M
Q3 24
$140.2M
$51.9M
Q2 24
$168.6M
$48.7M
Q1 24
$174.7M
$50.2M
Net Profit
MED
MED
PLYM
PLYM
Q4 25
Q3 25
$-2.3M
$-54.4M
Q2 25
$2.5M
$-6.1M
Q1 25
$-772.0K
$5.8M
Q4 24
$147.4M
Q3 24
$1.1M
$-15.6M
Q2 24
$-8.2M
$1.3M
Q1 24
$8.3M
$6.2M
Gross Margin
MED
MED
PLYM
PLYM
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
PLYM
PLYM
Q4 25
-10.4%
Q3 25
-4.6%
-102.5%
Q2 25
-1.0%
-10.3%
Q1 25
-1.1%
Q4 24
0.6%
Q3 24
1.5%
-29.6%
Q2 24
-4.7%
2.7%
Q1 24
4.5%
Net Margin
MED
MED
PLYM
PLYM
Q4 25
Q3 25
-2.5%
-106.3%
Q2 25
2.3%
-12.9%
Q1 25
-0.7%
12.8%
Q4 24
309.9%
Q3 24
0.8%
-30.1%
Q2 24
-4.8%
2.7%
Q1 24
4.8%
12.4%
EPS (diluted)
MED
MED
PLYM
PLYM
Q4 25
$-1.64
Q3 25
$-0.21
$-1.23
Q2 25
$0.22
$-0.14
Q1 25
$-0.07
$0.13
Q4 24
$0.08
$3.24
Q3 24
$0.10
$-0.35
Q2 24
$-0.75
$0.03
Q1 24
$0.76
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
PLYM
PLYM
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$470.1M
Total Assets
$248.0M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
PLYM
PLYM
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Total Debt
MED
MED
PLYM
PLYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$646.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MED
MED
PLYM
PLYM
Q4 25
$198.9M
Q3 25
$214.7M
$470.1M
Q2 25
$216.0M
$539.6M
Q1 25
$211.0M
$571.0M
Q4 24
$210.1M
$579.5M
Q3 24
$207.3M
$436.5M
Q2 24
$205.3M
$475.2M
Q1 24
$211.0M
$484.6M
Total Assets
MED
MED
PLYM
PLYM
Q4 25
$248.0M
Q3 25
$268.2M
$1.6B
Q2 25
$269.3M
$1.6B
Q1 25
$280.0M
$1.4B
Q4 24
$284.2M
$1.4B
Q3 24
$291.2M
$1.5B
Q2 24
$293.5M
$1.4B
Q1 24
$302.8M
$1.4B
Debt / Equity
MED
MED
PLYM
PLYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
PLYM
PLYM
Operating Cash FlowLast quarter
$-5.3M
$20.0M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
PLYM
PLYM
Q4 25
$-5.3M
Q3 25
$12.1M
$20.0M
Q2 25
$-3.4M
$23.4M
Q1 25
$3.4M
$15.6M
Q4 24
$-4.9M
$96.1M
Q3 24
$9.1M
$17.6M
Q2 24
$13.1M
$19.9M
Q1 24
$7.3M
$16.6M
Free Cash Flow
MED
MED
PLYM
PLYM
Q4 25
$-6.6M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
MED
MED
PLYM
PLYM
Q4 25
-8.8%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
MED
MED
PLYM
PLYM
Q4 25
1.8%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
MED
MED
PLYM
PLYM
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
2.67×
Q4 24
0.65×
Q3 24
8.04×
Q2 24
15.12×
Q1 24
0.88×
2.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons